Abstract:Purpose: Previous studies showed that genetic variants of the angiotensinogen (AGT) gene conferred higher risk for acquired atrial fibrillation (AF). The present study investigated whether AGT variants correlate with the clinical outcome in patients with acquired AF after catheter ablation (CA). Methods: A total of 150 acquired symptomatic drug-refractory AF patients (mean age 63.711.0 years, 24.6% non-paroxysmal AF) with acquired AF underwent a single CA procedure in our department and were included in this retrospective analysis. Eight tagging single nucleotide polymorphisms (tSNPs) in the AGT gene were genotyped. Standard electrocardiographs (ECGs) and 24-hour Holter recordings were performed during a median follow-up period of 57.5 months to detect AF recurrence. Results: Sixty-one patients (40.7%) suffered AF recurrences after a single CA procedure during follow up. Of the eight tSNPs, the frequency of the M allele of M235T was significantly higher in the recurrence group (28%) compared to the non-recurrence group (18%) (p=0.042). The recurrence rates of patients with the TT, MT, and MM genotypes were 34.4%, 50%, and 55.6%, respectively (p(trend)=0.049). After adjusting for age, sex, body mass index, hypertension, left atrial volume index (LAVI) and other covariates, M235T increased the risk of AF recurrence in additive and dominant models with odds ratios of 2.023 (95% confidence interval (CI): 1.034-3.926, p=0.033) and 2.601 (95% CI: 1.102-6.056, p=0.025), respectively. However, in multiple correction analyses, the p values of multiple comparisons were not statistically significant (p(correct)>0.05). Conclusions: The M allele of M235T might be associated with an increased risk of AF recurrence after CA. Genotyping may thus be helpful on identifying patients with higher risks of AF recurrence after CA and developing optimal follow-up strategies. These strategies may differ and should be individualized according to patients' genotype. Future studies are warranted to validate the potential effect of AGT M235T on AF recurrence post CA.

Gene Polymorphism and Recurrent Atrial Fibrillation after Catheter Ablation: A Comprehensive Review.

Current Understanding of Atrial Fibrillation Recurrence after Atrial Fibrillation Ablation: from Pulmonary Vein to Epicardium

The Genetics of Atrial Fibrillation: from the Bench to the Bedside.

Related predictors of atrial fibrillation recurrence after catheter ablation

Genetic basis of atrial fibrillation.

[Risk Factors for Atrial Fibrillation Recurrence after Catheter Ablation].

Related factors Analysis of recurrent atrial fibrillation after radiofrequency catheter ablation

Epigenetic Mechanism and Therapeutic Implications of Atrial Fibrillation

Risk and Protective Factors of Recurrence after Catheter Ablation for Atrial Fibrillation

Risk factors of long-term recurrence after catheter ablation in patients with atrial fibrillation

Common Variants Predict Recurrence after Nonfamilial Atrial Fibrillation Ablation in Chinese Han Population.

Association of the angiotensinogen M235T polymorphism with recurrence after catheter ablation of acquired atrial fibrillation

Variant rs2200733 and rs10033464 on chromosome 4q25 are associated with increased risk of atrial fibrillation after catheter ablation: Evidence from a meta-analysis.

Research Progress on the Factors Influencing the Recurrence of Atrial Fibrillation after Radiofrequency Ablation

Why Atrial Fibrillation Recurs in Patients Who Obtained Current Ablation Endpoints with Longstanding Persistent Atrial Fibrillation

Association of SCN10A Polymorphisms with the Recurrence of Atrial Fibrillation after Catheter Ablation in a Chinese Han Population

Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation

Association of Angiotensin-Converting Enzyme Gene I/D and CYP11B2 Gene −344T/C Polymorphisms with Lone Atrial Fibrillation and Its Recurrence after Catheter Ablation

Clinical Predictors of Recurrence after Circumferential Ablation of Pulmonary Vein Ostia to Treat Atrial Fibrillation

Advances in Basic and Translational Research in Atrial Fibrillation.

Atrial Fibrillation Genetic Considerations: The Basic Scientist'S Perspective